Now live: FDA · Health Canada · EU/UK 1169 · Gulf GSO · FSANZ · Swiss LIV · India FSSAI · Eurasian TR CU 022 · East African EAS 38 · CARICOM CRS 5 · MERCOSUR / ANVISA · Japan CAA label formats · true-scale KLD dielines · multilingual ingredient intelligence
regulatory

Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to the Harmonized Tariff Schedule of the United States for Duties Imposed Under Proclamation 11020

Federal Register (FDA/USDA food labeling) · United States · published 23 Sep 2026

This notice defines the pharmaceutical products and lists the jurisdictions that are eligible to receive an ad valorem tariff rate of zero pursuant to Presidential Proclamation 11020 of April 2, 2026, "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States," (Proclamation 11020). These pharmaceutical products include drugs and associated ingredients where all approved indications are designated as orphan; nuclear medicines; plasma derived therapies; fertility drugs; cell therapy product; gene therapy product; antibody drug conjugates; medical countermeasures related to chemical, biological, radiological, and nuclear threats; and animal health. Proclamation 11020 states that such products and associated ingredients receive the Section 232 zero tariff rate if they are products of a jurisdiction that has a current or forthcoming trade and security framework agreement or if they meet an urgent U.S. health need. This notice also includes procedures for th

Read the official notice →

Source: Federal Register (FDA/USDA food labeling) · US Government work (public domain). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.

More from United States

What this means for your label

A notice like this changes what a pack must carry. These are the rules we build against, starting with US FDA.

← All food-authority news